Business Description
Oxford BioDynamics is a UK-based biotechnology company focused on developing blood tests that help doctors make better treatment decisions for patients with serious diseases. Its core technology reads three-dimensional patterns in the genome to predict how individual patients will respond to specific therapies, including cancer immunotherapy. Founded in 2007 and operating across the United Kingdom and the United States, the company combines laboratory diagnostics with cloud-based data tools to bring precision medicine closer to everyday clinical practice.
